Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Association Between Menstrual Pain Severity and Plantar Pressure in Young Women

9 de noviembre de 2026 actualizado por: Al Hayah University In Cairo

Association Between Primary Dysmenorrhea Severity and Plantar Pressure Distribution in Post-Pubertal Females

Primary dysmenorrhea is a common condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. Menstrual pain may be accompanied by changes in posture, neuromuscular function, and postural control. These changes may influence how body weight is distributed across the feet during standing.

The purpose of this observational study is to investigate the association between primary dysmenorrhea severity and plantar pressure distribution in post-pubertal females.

The study will include 79 female university students aged 18-23 years with a history of primary dysmenorrhea. Participants will be recruited from the first through fourth academic years of the Faculty of Physical Therapy at Al Hayat University in Cairo, Egypt.

Each participant will undergo a single assessment during the menstrual phase, specifically within the first three days of menstruation.

Primary dysmenorrhea severity will be assessed using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The scale produces a total score ranging from 0 to 12, with higher scores indicating greater severity.

Plantar pressure distribution will be assessed using the DIERS pedoscan system during standardized barefoot quiet standing. The assessment will include plantar pressure distribution and anterior-posterior and right-left weight distribution.

A minimum of two valid 30-second standing measurements will be obtained and averaged for analysis.

The study will examine whether greater primary dysmenorrhea severity is associated with measurable differences in plantar pressure distribution and weight-bearing characteristics.

No therapeutic intervention, randomization, or experimental treatment allocation will be performed.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

De observación

Inscripción (Estimado)

79

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Aya O. Mohammed Sobhy
  • Número de teléfono: +201159880001
  • Correo electrónico: aya.osama@ahuc.edu.eg

Ubicaciones de estudio

      • New Cairo, Egipto
        • Reclutamiento
        • Alhayah University in Cairo

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 23 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Método de muestreo

Muestra no probabilística

Población de estudio

The study population consists of female undergraduate physical therapy students aged 18-23 years attending the first through fourth academic years at Al Hayat University in Cairo, Egypt. Eligible participants will have primary dysmenorrhea, regular menstrual cycles, and the ability to complete a standardized standing plantar pressure assessment. A total of 79 participants is planned. Each participant will be assessed during menstrual Days 1-3.

Descripción

Inclusion Criteria:

  • Post-pubertal females aged 18-23 years.
  • Regular menstrual cycles ranging from 21 to 35 days.
  • History consistent with primary dysmenorrhea for at least the previous six consecutive months.
  • Ability to stand independently without assistive devices for the duration of the pedobarographic assessment.
  • Provision of written informed consent before participation.

Exclusion Criteria:

  • Diagnosis of secondary dysmenorrhea, including endometriosis, adenomyosis, pelvic inflammatory disease, or uterine fibroids, confirmed clinically or through imaging.
  • Current or recent pregnancy.
  • Neurological disorders affecting balance or sensorimotor function.
  • Musculoskeletal injury or condition involving the lower limbs, feet, or lumbar spine within the preceding six months.
  • Foot deformity or structural lower-limb abnormality known to alter plantar pressure distribution.
  • Current use of medications known to influence postural control, including centrally acting analgesics, benzodiazepines, or antiepileptics.
  • History of major lower-limb or foot surgery.
  • Systemic disease affecting sensory or motor function, including diabetes mellitus or peripheral neuropathy.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: CASE_ONLY
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Post-Pubertal Females With Primary Dysmenorrhea

A single group of 79 post-pubertal females aged 18-23 years with primary dysmenorrhea will be recruited from undergraduate physical therapy students at Al Hayat University in Cairo. Participants will have regular menstrual cycles, a history of primary dysmenorrhea for at least six consecutive months, and the ability to stand independently for pedobarographic assessment. Dysmenorrhea severity and plantar pressure parameters will be assessed at a single visit during menstrual Days 1-3.

The exposure of interest is the severity of primary dysmenorrhea, quantified using the self-reported WaLIDD scale. The instrument evaluates working ability, pain location, pain intensity, and duration of pain. Each domain contributes 0-3 points to a total score ranging from 0 to 12. Higher scores indicate greater severity. Dysmenorrhea severity will be examined for its association with objectively measured plantar pressure distribution and weight-bearing characteristics during standing. This is an observed characteristic and not an investigator-assigned intervention.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Static Plantar Pressure Distribution
Periodo de tiempo: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

Plantar pressure distribution will be assessed using the DIERS pedoscan computerized pedobarographic platform during standardized barefoot quiet standing. Participants will stand with feet shoulder-width apart, arms relaxed at their sides, and eyes directed forward. At least two valid 30-second recordings will be obtained and averaged. The recorded plantar loading distribution will be analyzed in relation to primary dysmenorrhea severity. The precise regional pressure outputs and measurement units must be defined from the study's DIERS reporting protocol before submission.

Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.
Primary Dysmenorrhea Severity Assessed by WaLIDD Score
Periodo de tiempo: Single assessment during menstrual Days 1-3.

Primary dysmenorrhea severity will be quantified using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The instrument contains four domains, each scored from 0 to 3, resulting in a total score ranging from 0 to 12. Higher scores represent greater symptom severity. Scores are categorized as absent (0), mild (1-4), moderate (5-7), or severe (8-12). The total score will be used as the principal severity variable in the correlational analysis.

Single assessment during menstrual Days 1-3.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Anterior-Posterior Weight Distribution (%)
Periodo de tiempo: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

Anterior-posterior weight distribution will be measured using the DIERS pedoscan system during standardized barefoot quiet standing. The instrument will quantify the distribution of body weight between the anterior and posterior plantar regions, expressed as percentages. At least two valid 30-second recordings will be obtained and averaged for analysis.

Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.
Right-Left Weight Distribution (%)
Periodo de tiempo: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

Right-left weight distribution will be assessed using the DIERS pedoscan computerized pressure platform. The measurement will quantify the percentage of body weight distributed between the right and left lower limbs during standardized barefoot quiet standing. At least two valid 30-second recordings will be obtained and averaged for analysis.

Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

18 de noviembre de 2026

Finalización primaria (Estimado)

1 de febrero de 2027

Finalización del estudio (Estimado)

1 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

9 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Publicado por primera vez (Actual)

13 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • AOMS-PD-PPD-2026-001 Copy

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir